FDA Approved: SYFOVRE — Supplemental Application (Apellis Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for SYFOVRE (pegcetacoplan) from Apellis Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Geographic Atrophy

Drugs mentioned

• SYFOVRE (pegcetacoplan)

Snippet

SUPPL AP for SYFOVRE (PEGCETACOPLAN)